Two pharmaceutical companies in line for first conditional approval for their COVID-19 vaccine by the EU's medicine regulator said Wednesday their documents were "unlawfully accessed" during a cyberattack on a European Medicines ...
Dec 9, 2020
0
47
Most autism spectrum disorders have a complex, multifactorial genetic component, making it difficult to find specific treatments. Rett syndrome is an exception. Babies born with this form of the disorder have mutations specifically ...
Dec 8, 2020
0
190
Pfizer chief executive Albert Bourla said Tuesday he understands concerns around the speed at which pharmaceutical companies have produced COVID-19 vaccines, but insisted that no corners had been cut.
Dec 8, 2020
0
2
Pfizer's COVID-19 vaccine is entering the final phase of review before the U.S. government decides whether to allow millions to get the shots.
Dec 8, 2020
0
2
Provincial governments across China are placing orders for experimental, domestically made coronavirus vaccines, though health officials have yet to say how well they work or how they may reach the country's 1.4 billion people.
Dec 6, 2020
0
32
Shawn stepped into the UCLA Vine Street Clinic in Hollywood with confidence. He offered up his arm. The UCLA doctor injected him. It took seconds; there was barely a sting.
Dec 4, 2020
0
2
The Pfizer/BioNTech, Moderna and AstraZeneca/University of Oxford groups have all recently announced their COVID vaccine candidates have demonstrated high levels of efficacy in phase 3 trials. These developments have focused ...
Dec 2, 2020
0
1
Dozens of companies, from biotech start-ups to Big Pharma, are in the race to develop a safe and effective coronavirus vaccine, both to meet urgent medical need and for the potential payday.
Dec 2, 2020
0
1
Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against Covid-19 based on the yellow fever vaccine, which as a result also works against yellow fever. Results published today in ...
Dec 1, 2020
0
258
Moderna Inc. said Monday it was asking U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection—intensifying the race to begin limited vaccinations ...
Nov 30, 2020
0
0
